Skip to main content

Rapp Michael's Form 4 filing

Immunome Inc. (IMNM) · filed Sep 13, 2021

Accession no.
0001104659-21-114881
Filed
Sep 13, 2021
Trade date
Sep 9-10, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $830.4K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rapp MichaelCIK 0001405685Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 9, 2021Common StockPPurchaseAcquired+8,170$17.44F1+$142,484.8145,000Indirect
Sep 9, 2021Common StockPPurchaseAcquired+22,280$18.46F3+$411,288.8167,280Indirect
Sep 10, 2021Common StockPPurchaseAcquired+15,500$17.85F4+$276,675182,780Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $16.76 to $17.65, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $17.88 to $18.75, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $17.25 to $18.08, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)